# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2019382 | F | Cytotoxicity against PTEN wild type human HCC1954 cells after 6 days by alamar blue assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
2. | ALA985247 | F | Cytotoxicity against human HCC1954 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
3. | ALA1762917 | F | Antiproliferative activity against human HCC1954 harboring PI3K/p53 gene mutation/amplification at 1 uM after 72 hrs by Ambit assay in presence of 10% serum | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA2363262 | F | SANGER: Inhibition of human HCC1954 cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
5. | ALA2410309 | F | Antiproliferative activity against human HCC1954 cells assessed as growth inhibition after 5 days by SRB assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
6. | ALA5255836 | F | Antitumor activity against human HCC1954 cells xenografted in NCR nude mouse model assessed as tumor growth inhibition at 25 mg/kg via oral gavage administered for 28 days by caliper method | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
7. | ALA5255837 | F | Antitumor activity against human HCC1954 cells xenografted in NCR nude mouse model assessed as tumor growth inhibition at 25 mg/kg via oral gavage administered for 28 days in presence of trastuzumab/pertuzumab by caliper method | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
8. | ALA3271580 | F | Antiproliferative activity against human HCC1954 cells expressing HER2 assessed as growth inhibition after 24 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
9. | ALA3271581 | F | Antiproliferative activity against human HCC1954 cells expressing HER2 assessed as growth inhibition after 48 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
10. | ALA3271582 | F | Antiproliferative activity against human HCC1954 cells expressing HER2 assessed as growth inhibition after 72 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
11. | ALA3271583 | F | Antiproliferative activity against human HCC1954 cells expressing HER2 assessed as growth inhibition after 96 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
12. | ALA3370226 | F | Inhibition of lactate production in human HCC1954 cells up to 50 uM after 6 hrs by spectrophotometry | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
13. | ALA3370227 | F | Inhibition of lactate production in human HCC1954 cells after 6 hrs by spectrophotometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA3411384 | F | Growth inhibition of human HCC1954 cells after 5 days by SRB assay | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
15. | ALA3424562 | F | Cytotoxicity against human HCC1954 cells after 72 hrs by MTT assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA4001347 | F | Cytotoxicity against human HCC1954 cells at 5 uM by MTT assay | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
17. | ALA4001348 | F | Cytotoxicity against human HCC1954 cells at 10 uM by MTT assay | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
18. | ALA4001352 | F | Cytotoxicity against human HCC1954 cells by MTT assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
19. | ALA4001387 | F | Anti-tumor activity against HER2-amplified human HCC1954 cells xenografted in NOD/SCID mouse assessed as tumor size at 10 mg/kg, ip administered once daily for 18 days measured after 1 hr last dose (Rvb = 497 +/- 82 mm3) | Homo sapiens | 2 | organism-based format | Scientific Literature | ||
20. | ALA4001390 | F | Anti-tumor activity against HER2-amplified human HCC1954 cells xenografted in NOD/SCID mouse assessed as tumor weight at 10 mg/kg, ip administered once daily for 18 days measured after 1 hr last dose (Rvb = 0.8 +/- 0.07 g) | Homo sapiens | 1 | organism-based format | Scientific Literature |